Aspira Women's Health Corrects Warrant Termination Date in SEC Filing
Aspira Women’s Health Inc. has corrected the termination date of its Amended and Restated Series A Common Stock Warrants in a recent SEC filing. The company attached the correct warrant form as an exhibit to its amended report. This correction follows an earlier filing that contained the incorrect date.
Aspira Women’s Health Inc. has issued a correction regarding its previously disclosed Amended and Restated Series A Common Stock Warrants. The original filing included an incorrect termination date. The company has now attached the correct form of the warrant as an exhibit to its amended report. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women’s Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-105561), on November 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
